Fungal co-infections are commonly found in critically ill COVID-19 patients, highlighting the need for improved diagnostic methods.
The study identified 10 out of 43 patients with acute respiratory distress syndrome (ARDS) who tested positive for fungi using metagenomic next-generation sequencing (mNGS), which proved to be more effective than traditional tests.
The findings suggest that clinicians should be vigilant about the increased risk of fungal infections in COVID-19 patients, especially those with weakened immune systems, and utilize mNGS for timely diagnosis.